Europe Cell Sorting Market Overview
The Europe Cell Sorting Market is valued at US$ 89.78 million in 2025 and is projected to reach US$ 168.20 million by 2035 at a CAGR of 6.49% during the forecast period 2026–2035.
Cell sorting, also known as flow cytometry, is a technique to separate and purify different types of cells from a mixture based on specific physical or biochemical properties. A sample of cells is passed through a device called a flow cytometer, which uses lasers and detectors to analyze the cells one at a time as they flow through a small nozzle. The flow cytometer can identify and sort the cells into different populations based on predefined criteria by measuring various characteristics, such as size, shape, and fluorescence. Cell sorting is commonly used in biomedical research, clinical diagnosis, and cell-based therapy.
Europe Cell Sorting Market Report Scope
| Metrics | Details |
| Market CAGR | 6.49% |
| Segments Covered | By Technology, By Product and Services, By Application, By End User, and By Country |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
| Fastest Growing Country | United Kingdom |
Europe Cell Sorting Market Dynamics
The Europe cell sorting market growth is driven by increasing demand for cell-based research and therapies, government funding and research initiatives, advancements in technology, Growing use of cell sorting in personalized medicine, the growing number of pharmaceutical and biotechnology companies in Europe and the increasing number of clinical trials and research activities in Europe.
Increasing demand for cell-based research and therapies drives the market growth
Cell-based therapies and regenerative medicine are growing rapidly in Europe, driving the need for advanced cell sorting techniques to isolate and purify specific cell populations. The increasing demand for cell-based research and therapies, including regenerative medicine and cell-based therapies, is one of the major driving factors for the growth of the biological cell sorting market in Europe. Cell-based therapies and regenerative medicine can revolutionize how diseases are treated, and cell-sorting techniques are essential to isolate and purify specific cell populations for these therapies. Cell sorting is also used to identify and isolate specific cell populations for basic research, drug discovery, and developing new therapeutic compounds. As cell-based therapies and regenerative medicine continue to grow, the demand for cell-sorting technologies will also increase.
In addition, in March 2021, Roche (Basel, Switzerland) and Bio-Rad Laboratories (Hercules, CA, USA) entered into a global partnership to provide their customers access to Bio-Rad's complete line of InteliQ products and Unity QC data management solutions along with customer training and support services.
The high cost of cell sorting instruments will hamper the growth of the market
However, high cost of cell sorting instruments is a limiting factor for the growth of the biological cell sorting market in Europe. Cell sorting instruments can be relatively expensive, making it difficult for some research and clinical settings, particularly in resource-limited countries, to afford the equipment and reagents necessary for cell sorting. This may limit the use of cell sorting technologies in some areas and slow market growth. Additionally, the high cost of cell sorting instruments may make it difficult for small and medium-sized companies to enter the market and compete with established players.
Europe Cell Sorting Market Segment Analysis
The Fluorescence activated cell sorting (FACS) segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)
The Fluorescence activated cell sorting (FACS) segment accounts for the highest market share. Fluorescence-activated cell sorting is used to sort and purify cells based on their fluorescence properties. FACS is commonly used in cell biology, immunology, and stem cell research. It allows researchers to isolate specific cell populations based on one or more fluorescence markers. The basic principle of FACS is that cells are labeled with fluorescent dyes or proteins and then passed through a FACS machine, which uses lasers and detectors to measure the fluorescence of each cell as it passes through a small nozzle. The machine can then sort the cells based on their fluorescence properties into different populations.
FACS has several advantages over other cell sorting techniques, including high sorting efficiency, high purity of sorted cells, and the ability to sort cells based on multiple markers. It also can sort cells based on their DNA content, making it useful for studying cell cycle and cell proliferation.
Europe Cell Sorting Market Geographical Analysis
UK region holds the largest market share of the Europe cell sorting market
The U.K dominates the market for cell sorting and is expected to show a similar trend over the forecast period. The market is driven by the presence of renowned research centers and Universities, the increasing number of clinical trials and research activities, and the presence of many pharmaceutical and biotechnology key players in the United Kingdom region.
Over 1,000 ties between academics and the pharmaceutical business were found in a recent ABPI assessment of 15 companies, demonstrating the high level of collaboration in the UK life sciences sector.
In addition, in terms of clinical research, the U.K is one of the top three locations for delivering early-stage commercial studies, and in 2019 it was responsible for 12% of all global trials for novel cell and gene therapies. Over the past year, 40,000 people signed up for the RECOVERY trial, much larger than previous comparable COVID-19 trials, bringing the total number of participants from across the UK to over 1 million.
Europe Cell Sorting Market Competitive Landscape
The cell sorting market is a moderately competitive presence of local and domestic companies. Some of the key players which are contributing to the growth of the market are Bio-Rad Laboratories, Inc., Sony Biotechnology Inc., Becton, Dickinson and Company, Merck KGaA, Danaher Corporation, Miltenyi Biotec GmbH, Affymetrix, Inc, Sysmex Partec GmbH, Union Biometrica, Inc., and pluriSelect Life Science UG & Co. KG, among others. The major players are adopting several growth strategies, such as Type launches, acquisitions, and collaborations, contributing to the growth of the cell sorting market.
For instance,
- In March 2021, BD agreed with ImageMovers. This software platform automates and simplifies medical data collection and management to offer a companion mobile app that enables more streamlined reporting of SARS-CoV-2 antigen testing results performed on the BD Veritor Plus System at everyday testing locations such as schools and businesses. The ImageMovers app is available immediately for BD Veritor Plus System customers.
Bio-Rad Laboratories, Inc.
Overview:
Bio-Rad is developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for 70 years, the company's products advance the discovery process and improve healthcare. The company's customers include university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, and applied laboratories that include food safety and environmental quality.
Product Portfolio:
S3e Cell Sorter: FACS, or fluorescence-activated cell sorting, is now simpler and more widely available. Users can execute 1-4 color sorts with our lab's automated S3e Cell Sorter due to its distinctive feature set and technological simplicity.
The Europe Cell Sorting market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.
Recent Developments in the Europe Cell Sorting Market
- Sysmex Europe and Cytek Biosciences expand clinical flow cytometry access - September 2026: The companies announced a collaboration covering more than a dozen European countries. The initiative combines their technologies to support integrated clinical laboratory workflows, advanced multicolor analysis, and improved standardization.
- GIMM installs a new spectral cell sorter in Portugal - June 2026: The Gulbenkian Institute for Molecular Medicine expanded its flow cytometry capabilities with a spectral sorter that can analyze up to 50 parameters simultaneously. The platform supports the isolation of cell populations for downstream applications such as proteomics, metabolomics, and molecular analysis.
- Sartorius launches CellCelector CLD - April 2026: Sartorius introduced an automated imaging and cell-isolation platform designed to accelerate monoclonal cell line development. The system combines high-speed scanning, imaging, and gentle cell retrieval, with automated documentation to support traceability and downstream research workflows.
- ThinkCyte installs its first VisionSort system in Italy - January 2026: ThinkCyte and its Italian distributor established a demonstration installation intended to serve researchers and biopharmaceutical companies across Italy, Spain, and Portugal. The move gives Southern European users local access to its AI-based cell analysis and sorting platform.
- Fraunhofer IZI-BB and Yokogawa advance image-activated cell sorting research - February 2026: The organizations outlined a project connecting single-cell injection with downstream sorting and clonal cell-line development. The collaboration also explores the use of algae as a potential cell factory, demonstrating opportunities for sorting technologies beyond conventional biomedical research.
